Cite
MLA Citation
Brian I Rini et al.. “Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.” Lancet, vol. 393, no. 10189, 2019, pp. 2404–2415. http://access.bl.uk/ark:/81055/vdc_100086499986.0x00004c